| CCO > Hepatitis > HBV > Pathogenesis and Natural History |
Thursday, August 21, 2008 |
|
Pathogenesis & Natural History
By: Robert G. Gish, MD
|
Join Robert G. Gish, MD, as he discusses the epidemiology and natural history of HBV.
Date Posted: 6/26/2008
|
By: Marc G. Ghany, MD
|
Marc G. Ghany, MD, discusses cccDNA and its role in the difficult path of obtaining a true cure for HBV infection
Date Posted: 6/25/2008
|
 |
Download a HBV core curriculum slideset on the epidemiology and natural history of HBV for self study or use in your own presentations.
File Format: Microsoft PowerPoint (.ppt) | File Size: 2,019 KB
Date Posted: 6/24/2008
|
By: Robert G. Gish, MD, Josep M. Llovet, MD, Paul Martin, MD
|
Join Robert G. Gish, MD; Josep M. Llovet, MD; and Paul Martin, MD, as they discuss the most recent data on special hepatic issues and populations presented at the 43rd Annual Meeting of the European Association for the Study of the Liver.
Date Posted: 6/23/2008
|
 |
Download and review key data selected by Daniel Shouval, MD on clinical HBV data that was presented at the 2008 EASL meeting in Milan. Use the slides in your own presentations!
File Format: Microsoft PowerPoint (.ppt) | File Size: 948 KB
Date Posted: 5/9/2008
|
|
Nearly one half of chronic hepatitis B patients from Indian cohort shown to be insulin resistant
Date Posted: 4/29/2008
|
|
10-year retrospective analysis suggests nucleoside analogue treatment not recommended for patients with HBV-related acute liver failure.
Date Posted: 11/9/2007
|
|
12-year observational study reveals that elevated HBV DNA levels are associated with liver disease progression.
Date Posted: 11/9/2007
|
|
Metabolic intervention may be warranted for hepatic steatosis in HBV patients as it is associated with factors such as body mass index, cholesterol levels, and serum triglycerides.
Date Posted: 11/7/2007
|
|
Trajectory modeling of REVEAL data illustrates that changes in HBV DNA levels over time can predict the risk of developing HCC
Date Posted: 11/7/2007
|
|
Featured Content
Expert faculty members review the most important advances in hepatitis and its mgmt in 2008.
Join our experts as they review treatment options for patients with nonresponse to HCV therapy.
2008 Independent Conference Report on Hepatitis B and C Virus Resistance to Antiviral Therapies.
|
|